Aristo Bio-Tech and Lifescience Limited

Aristo Bio-Tech and Lifescience Limited - chemicals in Vadodara, Gujarat, India. FY 2026 financials & compliance.
CIN L01100GJ2005PLC127397 Incorporated 17 March 2005 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Listed - NSE: ARISTO Public Limited Company chemicals MSME · Medium
Market Cap
₹80.26 Cr
ARISTO-SM · NSE
Share Price
₹123.00
+4.33% today
Revenue
₹364 Cr
FY 2025-26 · +14.3% YoY
EBITDA
₹16.05 Cr
Margin 4.4%
Net Profit
₹7.19 Cr
FY 2025-26 · +79.3% YoY
P/E (TTM)
11.2x
P/B 1.8x
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹6.81 Cr
Issued & subscribed

About Aristo Bio-Tech and Lifescience Limited

Data last updated:

Aristo Bio-Tech and Lifescience Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 17 March 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L01100GJ2005PLC127397. Its GSTIN is 24AAFCA1552P1ZL (Gujarat). The company holds 6 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on NSE: ARISTO.

The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.81 Cr. It was formerly known as Aristo Bio-Tech and Lifescience Private Limited. It is led by directors including Narendra Singh Barhat (Managing Director) and Ketankumar Harkantbhai Joshi (Whole-Time Director).

Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at E – 24 25 26 G.I.D.C. Manjusar Ta. Savli, Vadodara, Gujarat, India – 391775.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹363.72 Cr, a growth of 14.3% compared to the previous year. For the same year it recorded a net profit of ₹7.19 Cr (net margin 2%) and EBITDA of ₹16.05 Cr (EBITDA margin 4.4%). The net worth stands at ₹44.11 Cr (up 18.2% YoY). Total assets are valued at ₹79.5 Cr (up 34.3% YoY).

The company has about 67 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Aristo Biotech. As per MCA filings, the company has open charges of ₹73.42 Cr and satisfied charges of ₹9.61 Cr on record. Court records list 11 cases involving the company, including 8 filed by the company and 3 filed against it; 1 case is pending. The company has 4 deals on record (3 funding rounds, 1 ipo), with disclosed funding of ₹1.19 Cr; the latest was in January 2023. Its 6 peer companies in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Iffco-Mc Crop Science Private Limited with revenue of ₹364.68 Cr. The company has 16 MSME Form 1 returns on record between 2017 and 2022, listing 854 overdue payments to 60 micro and small suppliers.

Aristo Bio-Tech and Lifescience Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0003717). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aristobiotech.com.

Company details

CIN L01100GJ2005PLC127397
Registration Number 127397
Incorporation Date 17 March 2005
ROC Ahmedabad
Listing Status Listed (NSE: ARISTO)
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0003717

CIN history

Aristo Bio-Tech and Lifescience has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L01100GJ2005PLC127397, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L01100GJ2005PLC127397Current
U01100GJ2005PLC127397Previous
U01100MH2005PTC152037Previous
U01100MH2005PLC152037Previous

Recognitions & Rankings of Aristo Bio-Tech and Lifescience

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-24-0003717

Contact details

Aristo Bio-Tech and Lifescience Limited's registered office is in Vadodara, Gujarat. Its website is aristobiotech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    E – 24 25 26 G.I.D.C. Manjusar Ta. Savli, Vadodara, Gujarat, India – 391775
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals

To see the full contact details of Aristo Bio-Tech and Lifescience Limited, buy the company report.

Comprehensive company report
Aristo Bio-Tech and Lifescience Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Aristo Bio-Tech and Lifescience operates one associated brand: Aristo Biotech. Each brand links to its own profile.

BrandDescriptionWebsite
Audio news content is provided to radio stations for broadcast.aristobiotech.com

Business activity

The main business activity of Aristo Bio-Tech and Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Aristo Bio-Tech and Lifescience Limited, buy the company report.

Financials of Aristo Bio-Tech and Lifescience Limited

FY 2025-26 filings available

Aristo Bio-Tech and Lifescience Limited reported revenue of ₹363.72 Cr (up 14.3% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹364 Cr
+14.3% YoY
EBITDA
₹16.05 Cr
+73.1% YoY
Profit After Tax
₹7.19 Cr
+79.3% YoY
Net Worth
₹44.11 Cr
+18.2% YoY
Total Assets
₹79.50 Cr
+34.3% YoY
Total Debt
₹35.40 Cr
+62.0% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue364318245218166167201
Revenue growth+14.3%+29.8%+12.5%+31.3%-0.7%-16.9%-
EBITDA16.059.278.498.705.474.354.50
EBITDA margin+4.4%+2.9%+3.5%+4.0%+3.3%+2.6%+2.2%
Profit before tax9.705.465.414.742.051.501.39
Net profit7.194.013.903.561.471.081.00
Net profit margin+2.0%+1.3%+1.6%+1.6%+0.9%+0.7%+0.5%
EPS (₹)10.555.975.725.232.932.152.02
Balance sheet
Total assets79.5059.1954.4852.6740.3335.6332.01
Net worth44.1137.3333.6130.1614.8513.3912.31
Total debt35.4021.8520.8722.4925.4822.2519.71
Cash & bank2.631.120.641.850.420.110.53
Net working capital54.4634.4132.3435.9425.9723.3220.87
Cash flow
Cash from operations8.8510.027.60(2.78)6.822.281.41
Cash from investing(2.97)(5.15)(6.61)(3.75)(3.19)(1.98)(2.19)
Cash from financing(4.37)(4.39)(2.21)7.97(3.33)(0.72)0.87

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 16 Nov 2026
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue364318245218166167201
Revenue growth+14.3%+29.8%+12.5%+31.3%-0.7%-16.9%-
Other income0.460.450.180.330.040.010.01
Total expenses348309237209161163197
Employee cost0.003.082.654.744.292.522.72
EBITDA16.059.278.498.705.474.354.50
EBITDA margin+4.4%+2.9%+3.5%+4.0%+3.3%+2.6%+2.2%
Depreciation2.922.601.571.541.100.750.52
Interest3.891.661.692.752.362.112.60
Profit before tax9.705.465.414.742.051.501.39
Tax2.511.401.511.180.570.420.39
Net profit7.194.013.903.561.471.081.00
Net profit margin+2.0%+1.3%+1.6%+1.6%+0.9%+0.7%+0.5%
EPS (₹)10.555.975.725.232.932.152.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital6.816.816.816.815.005.005.00
Reserves & surplus37.3030.5226.8023.359.858.397.31
Shareholders' funds (net worth)44.1137.3333.6130.1614.8513.3912.31
Secured loans32.0718.0616.7518.8322.0418.6113.87
Unsecured loans3.333.794.123.663.443.645.84
Total debt35.4021.8520.8722.4925.4822.2519.71
Total liabilities79.5059.1954.4852.6740.3335.6332.01
Assets
Gross block37.3734.7630.2022.7419.9416.8812.08
Net block23.6323.9521.6915.6214.3612.318.26
Capital work in progress0.000.000.001.100.100.002.82
Investments0.180.000.000.000.000.000.00
Inventories63.2147.3740.1930.7824.3631.9524.32
Sundry debtors54.7356.1857.4744.5733.2032.7748.31
Cash & bank balances2.631.120.641.850.420.110.53
Loans & advances9.5911.106.735.904.564.283.55
Total current assets13011610583.1062.5469.1176.71
Total current liabilities75.7081.3672.6947.1636.5745.7955.84
Net working capital54.4634.4132.3435.9425.9723.3220.87
Total assets79.5059.1954.4852.6740.3335.6332.01
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1.120.641.850.420.110.530.44
Net cash from operating activities8.8510.027.60(2.78)6.822.281.41
Net cash from investing activities(2.97)(5.15)(6.61)(3.75)(3.19)(1.98)(2.19)
Net cash from financing activities(4.37)(4.39)(2.21)7.97(3.33)(0.72)0.87
Net change in cash1.510.48(1.22)1.440.31(0.41)0.09
Closing cash2.631.120.641.850.420.110.53
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+14.3%+29.8%+12.5%+31.3%-0.7%-16.9%-
EBITDA growth+73.1%+9.2%-2.4%+59.1%+25.8%-3.3%-
PBT growth+77.7%+0.9%+14.1%+131.2%+36.7%+7.9%-66.1%
Net income growth+79.3%+2.8%+9.6%+142.2%+36.1%+8.0%-
Revenue CAGR (3Y)+18.6%+24.2%+13.6%+2.7%-6.3%-14.9%+7.9%
EBITDA CAGR (3Y)+22.7%+19.2%+25.0%+24.6%-6.8%-15.9%+21.0%
Profitability & leverage
Net income margin+2.0%+1.3%+1.6%+1.6%+0.9%+0.7%+0.5%
Return on capital employed-+12.5%+13.3%+16.1%+11.6%+10.7%+13.9%
Return on net worth-+11.5%+12.2%+15.8%+10.3%+8.4%+8.6%
Debt / equity-0.600.681.071.691.631.45
Long-term debt / equity-0.250.320.470.820.880.76
Interest cover29.6324.8924.4238.4154.0058.6165.33
Efficiency & per share
Fixed asset turnover-9.799.2610.2110.3813.5420.22
Inventory turnover-7.276.917.906.796.978.22
Debtors turnover-5.604.805.605.804.845.20
EPS (₹)10.555.975.725.232.932.152.02
Dividend per share (₹)0.600.500.400.250.000.000.00
Book value per share (₹)0.0054.8449.3744.3029.7126.7924.63

To see the full year-wise statements and ratios of Aristo Bio-Tech and Lifescience Limited, buy the company report.

Board of directors of Aristo Bio-Tech and Lifescience Limited

Aristo Bio-Tech and Lifescience has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Raghavender MatetiDirector10 Sep 20188 Years 2 MonthsCurrent
Laxman Singh RathoreDirector20 Mar 20224 Years 7 MonthsCurrent
Kusum Narendra Singh BarhatDirector17 Mar 200521 Years 8 MonthsCurrent
Narendra Singh BarhatManaging Director17 Mar 200521 Years 8 MonthsCurrent
Ketankumar Harkantbhai JoshiWhole-Time Director27 Aug 20188 Years 2 MonthsCurrent
Rashmi Kamlesh OtavaniDirector20 Mar 20224 Years 7 MonthsCurrent

Peer comparison

Aristo Bio-Tech and Lifescience Limited is compared with the 6 companies closest to it by revenue in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Iffco-Mc Crop Science Private Limited₹364.68 Cr (FY 2025)7.0%New Delhi, Delhi, India
Aristo Bio-Tech and Lifescience Limitedthis company₹363.72 Cr (FY 2026)₹7.19 Cr2%14.3%67Vadodara, Gujarat, India
Spectrum Ethers Private Limited₹354.8 Cr (FY 2025)16.0%Nashik, Maharashtra, India
Ramcides Cropscience Private Limited₹346.13 Cr (FY 2025)14.0%Chennai, Tamil Nadu, India
Sumil Chemical Industries Private Limited₹325.3 Cr (FY 2025)-1.0%Mumbai, Maharashtra, India
Shivalik Crop Sciences Private Limited₹317.93 Cr (FY 2025)12.0%Chandigarh, India
Agrico Organics Limited₹300.46 Cr (FY 2025)12.0%Delhi, India

To see the full peer comparison of Aristo Bio-Tech and Lifescience Limited, buy the company report.

Auditor

Aristo Bio-Tech and Lifescience Limited is audited by PRAKASH CHANDRA JAIN & CO. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
PRAKASH CHANDRA JAIN & CO.FY 2024002438C

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 73.40%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 26.60%.

Promoters: 73.40%Retail & Others: 26.60%
Sep 2026
QUARTER
73.40% Promoters
26.60% Retail & Others
Promoter holding - history
Now 73.40% · Sep 2026High 73.40% · Dec 2025Low 73.40% · Dec 2025
72%72.8%73.5%74.3%75%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 73.40%Mar 2026: 73.40%Jun 2026: 73.40%Sep 2026: 73.40%73.40%73.40%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters73.40%73.40%73.40%73.40%
Public26.60%26.60%26.60%26.60%

Charges & borrowings

Open charges
₹73.42 Cr
Satisfied charges
₹9.61 Cr
Breakdown by lending institutions
Others₹67.94 Cr
Sidbi₹4.49 Cr
Standard Chartered Bank₹1.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
08 Apr 2026101283930Others₹96.68 LakhOpen
30 Mar 2026101282317Sidbi₹75 LakhOpen
31 Dec 2025101207130Sidbi₹1 CrOpen
28 Aug 2025101151870Standard Chartered Bank₹1 CrOpen
18 Feb 2025101054045Sidbi₹2.74 CrOpen

To see the full charge records of Aristo Bio-Tech and Lifescience Limited, buy the company report.

Total charge records: 14 View all charges

Deals & funding

Aristo Bio-Tech and Lifescience Limited has 4 deals on record (3 funding rounds, 1 ipo), with disclosed funding of ₹1.19 Cr; the latest was in January 2023.

Total deals
4
Funding rounds
3
IPO
1
Disclosed funding
₹1.19 Cr

Deals on record (4 of 4)

WhenDealAmountParties
Jan 2023IPO₹13.05 CrInvestors: IPO Shareholders - Aristo Bio-Tech And Lifescience Limited
Mar 2012Funding round₹59.9 LakhInvestors: 4 individuals
Mar 2012Funding round₹10 LakhInvestors: an individual
Mar 2007Funding round₹49 LakhInvestors: Narendra Singh Barhat HUF, 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Aristo Bio-Tech and Lifescience Limited was last rated by Crisil on 27 Oct 2020.

Rating agencyRated onRating
Crisil27 Oct 2020

To see the full credit ratings and regulatory alerts of Aristo Bio-Tech and Lifescience Limited, buy the company report.

MSME payment delays

Aristo Bio-Tech and Lifescience Limited has 16 MSME Form 1 returns on record between 2017 and 2022, listing 854 overdue payments to 60 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 60)

SupplierAmount dueDue sinceReported on
Sanjay Chemicals (India) Private Limited
Anshikha Polysurf Ltd
Supreme India Cargo
Amish Crop Sciences Private Limited
Unitop Chemicals Private Limited

To see the full MSME payment records of Aristo Bio-Tech and Lifescience Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Aristo Bio-Tech and Lifescience Limited has a workforce of 67 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
67
Active EPFO establishments
1
Employee growth
26.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2767
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Aristo Bio-Tech and Lifescience Limited, buy the company report.

GST

Aristo Bio-Tech and Lifescience has 6 GST registrations: 1 active and 5 cancelled or inactive.

Total GSTINs
6
Active
1
Cancelled / inactive
5
GSTINStateStatusRegistered on
24AAFCA1552P1ZLGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Aristo Bio-Tech and Lifescience Limited, buy the company report.

Recent activity

Aristo Bio-Tech and Lifescience Limited has 14 board changes on record since 2005: 10 appointments and 4 cessations. The latest: Ayushi Aditya Deora ceased to be Company Secretary on 29 May 2025.

Charges
A charge with Others amounted to Rs. 0.97 Cr with Charge ID 101283930 was registered on 08 Apr 2026.
Filing
Aristo Bio-Tech And Lifescience Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Charges
A charge with Sidbi amounted to Rs. 0.75 Cr with Charge ID 101282317 was registered on 30 Mar 2026.
Charges
A charge with Sidbi amounted to Rs. 1.00 Cr with Charge ID 101207130 was registered on 31 Dec 2025.
AGM
Aristo Bio-Tech And Lifescience Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records.
Charges
A charge with Standard Chartered Bank amounted to Rs. 1.00 Cr with Charge ID 101151870 was registered on 28 Aug 2025.
Charges
A charge with Others of Rs. 30.35 Cr registered on 11 Jan 2007 with Charge ID 10036380 was modified on 16 Jun 2025.
Charges
A charge with Others of Rs. 30.35 Cr registered on 11 Jan 2007 with Charge ID 10035104 was modified on 13 Jun 2025.
Ceased
Ayushi Aditya Deora ceased to be Company Secretary.
Charges
A charge with Sidbi amounted to Rs. 2.74 Cr with Charge ID 101054045 was registered on 18 Feb 2025.
Appointed
Ayushi Aditya Deora was appointed as Company Secretary.
Ceased
Dipakkumar Harkant Joshi ceased to be Director.

26 earlier events are in the company report.

Frequently asked questions

Aristo Bio-Tech and Lifescience is an active public limited company based in Vadodara, Gujarat, India. The company works in chemical products, within the chemicals industry. It was incorporated on 17 March 2005 (21+ years old) and is registered under CIN L01100GJ2005PLC127397. Listed on NSE: ARISTO.

Aristo Bio-Tech and Lifescience reported revenue of ₹363.72 Cr for FY 2025-26 (up 14.3% YoY) based on standalone financials.

Aristo Bio-Tech and Lifescience has 6 current directors:

The latest financial statements of Aristo Bio-Tech and Lifescience on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 08 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Aristo Bio-Tech and Lifescience is 24AAFCA1552P1ZL, registered in Gujarat. The company has 6 GST registrations in all, of which 1 is active and 5 are cancelled or inactive.

The CIN (Corporate Identification Number) of Aristo Bio-Tech and Lifescience is L01100GJ2005PLC127397. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Aristo Bio-Tech and Lifescience is a listed company as per MCA records. Its shares are listed on NSE (symbol: ARISTO).

Aristo Bio-Tech and Lifescience has 11 court cases on record: 8 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.

Aristo Bio-Tech and Lifescience was incorporated on 17 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Aristo Bio-Tech and Lifescience has 4 deals on record (3 funding rounds, 1 ipo), with disclosed funding of ₹1.19 Cr; the latest was in January 2023.

The peers of Aristo Bio-Tech and Lifescience by revenue are Iffco-Mc Crop Science Private Limited, Spectrum Ethers Private Limited, Ramcides Cropscience Private Limited, Sumil Chemical Industries Private Limited, Shivalik Crop Sciences Private Limited and 1 more, all in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ayushi Aditya Deora ceased to be Company Secretary on 29 May 2025. Ayushi Aditya Deora was appointed as Company Secretary on 19 Mar 2024. Dipakkumar Harkant Joshi ceased to be Director on 08 Nov 2023. Aristo Bio-Tech and Lifescience has 14 board changes on record in total.